Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A new study has raised serious concerns about Ozempic, the weight-loss drug taking the world by storm. While it has reportedly helped many people manage their weight and regulate blood sugar, recent research has uncovered an alarming and unexpected side effect: vision loss.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise benefits besides shedding pounds soon surfaced. One of those – that the medication changed drinking and smoking habits overnight – understandably piqued the interest

A recent study suggests a potential link between Ozempic and vision loss, particularly non-arteritic anterior ischemic optic neuropathy (NAION), raising concerns about rapid blood sugar reduction affecting eye health.